HIV-1 subtype C in vitro growth and coreceptor utilization

Thumbi Ndung'u1, Enoch Sepako, Mary Fran McLane

  • 1Botswana-Harvard School of Public Health AIDS Initiative Partnership for HIV Research and Education, Private Bag BO320, Bontleng, Gaborone, Botswana, Africa.

Virology
|January 13, 2006
PubMed

Insights

Human immunodeficiency virus type 1 subtype C (HIV-1C) predominantly uses R5 and dualtropic X4R5 coreceptors for entry in Botswana. This suggests HIV-1C does not evolve to a pure X4 phenotype, impacting treatment strategies.

Area of Science:

  • Virology
  • Immunology
  • Epidemiology

Background:

  • Human immunodeficiency virus type 1 subtype C (HIV-1C) is the most prevalent globally, causing approximately 50% of infections.
  • Southern Africa bears a significant burden of HIV-1C, necessitating research into its unique biological characteristics.
  • Understanding HIV-1C tropism is crucial for developing effective interventions.

Purpose of the Study:

  • To investigate the chemokine receptor usage of HIV-1C isolates from Botswana.
  • To determine the predominant coreceptor tropism of HIV-1C in this region.
  • To assess potential evolution of HIV-1C tropism over the course of infection.

Main Methods:

  • Generation of HIV-1C virus isolates from infected individuals at various disease stages.
  • Analysis of coreceptor tropism, specifically chemokine receptor usage (CCR5 and CXCR4).
  • Phenotypic characterization of virus entry based on coreceptor utilization.

Main Results:

  • The R5 tropism (CCR5-using) was predominant among the studied HIV-1C isolates.
  • A smaller proportion of viruses exhibited dualtropic X4R5 (CCR5 and CXCR4-using) tropism.
  • No viruses with pure X4 tropism (CXCR4-only using) were identified, indicating a lack of evolution towards this phenotype.

Conclusions:

  • HIV-1C in Botswana primarily utilizes R5 and X4R5 coreceptors for entry.
  • The absence of X4-only tropism suggests limited viral evolution towards this entry pathway in the aging epidemic.
  • These findings have significant implications for the design and efficacy testing of antiretroviral therapies and prevention strategies.